Eric Tomlinson DSc, PhD
Eric Tomlinson, DSc, PhD is chief innovation officer of
Wake Forest Baptist Medical Center and president of Wake Forest Innovation
innovation officer, Tomlinson leads Wake Forest Innovations to improve health
through collaborative innovation between industry and faculty and staff of the
Innovations comprises three centers: the Center for Technology Innovation &
Commercialization, which accelerates the development and commercialization of
inventions; the Center for Industry Research Collaboration, which expedites
access to specialized clinical and research capabilities; and the Center for
Applied Learning, which promotes best clinical practices through experiential
As president of
the Wake Forest Innovation Quarter, Tomlinson helps drive economic
growth in the region by leading the formation of a knowledge-based economy
centered in the Innovation Quarter and across its partners by developing a
dynamic place to work, live, learn and play.
An enterprise of Wake Forest Baptist Medical Center in
collaboration with private developers, the City of Winston-Salem and Forsyth
County, the Innovation Quarter is a rapidly developing district for innovation
situated next to downtown Winston-Salem, NC. It’s a place for research,
business and education in biomedical science, information technology, clinical
services, engineering and advanced materials.
As of September 2016, it’s home to more than 65
companies, 5 academic institutions, 3,200 workers and several thousand
students undertaking degreed and workforce training programs.
Tomlinson has a background as a scientific and business
leader working both in early-stage and clinical stage biotechnology companies
and within a global pharmaceutical company.
He has built companies and teams from their inception and
fund-raising—to their development of biological and small drug/device
combination products and gene therapy products. He has transacted mergers of
publicly traded companies and raised both private and public equity corporate
financings in addition to broad-based product licensing and commercialization
agreements with major pharmaceutical companies.
Tomlinson has held academic appointments in the United States
and in Europe, including professor in the department of pharmacy at the
University of Amsterdam from 1979–1983.
He has co-authored 230 research publications in life
sciences and pharmaceutical sciences, including solution thermodynamics, drug
design, site-specific drug delivery and gene therapy.